Nadolol: What it is used for and side effects

belonging to the group of beta-blockers which is used in the treatment of hypertension and some types of heart diseases and disorders.

Shutterstock Nadolol - Chemical Structure

To date (June 2021), nadolol is available on the Italian pharmaceutical market within a single drug with the trade name Nadololo Cheplapharm (to be precise, it is a generic drug) formulated in tablets for oral use containing 80 mg of the principle active.

In order to be sold, this medicine requires presentation of a repeatable medical prescription (RR); being classified as a class C drug, its cost is fully borne by the citizen.

in patients who have not responded adequately to the elimination of the factors that favor it (for example, control of body weight, rest, smoking cessation, administration of nitroglycerin);

Cardiac arrhythmias such as:

• Paroxysmal atrial tachycardia;
• Paroxysmal atrial fibrillation;
• Ventricular and supraventricular extrasystoles;

Cardiovascular manifestations in patients with thyroid gland disorders (hyperthyroidism);

Other heart problems due to conditions such as obstructive cardiomyopathy.

and lungs;

Pathologies of the thyroid gland;

Have experienced severe allergic reactions to other drugs, food, insect bites, etc .;

Altered liver and / or renal function;

Diabetes.

During treatment with nadolol, however, the doctor should be informed:

• If you have to undergo surgery, since taking the active ingredient can increase the risks associated with anesthesia (the doctor who will perform the operation and the anesthetist must also be made aware of any therapy with nadolol in place ).
• If you have to undergo an exercise test, as nadolol can affect its accuracy.
• If signs or symptoms of any kind appear, as your intervention may be required to modify or discontinue therapy.

Regarding the suspension of therapy, please note that this should never be interrupted abruptly, even more so if you suffer from angina pectoris or if you have manifestations of coronary arterial insufficiency. This is because abrupt cessation of treatment in such situations can cause worsening of chest pain and an increased risk of heart attack.

Therefore, if necessary, the doctor will reduce the dose of nadolol administered, but gradually over a period of at least two weeks, subjecting the patient to close monitoring. acute coronary insufficiency, the doctor must be informed immediately and will proceed to restore the intake of nadolol, at least temporarily, prescribing adequate therapy to the patient.

If you miss a dose it is very important not to double the next dose and not to take the missed one if the next one is due within the next 8 hours. If in doubt, contact your doctor.